Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial

被引:0
作者
Kentaro Sugano
Teiji Kontani
Shinichi Katsuo
Yoshinori Takei
Nobuhiro Sakaki
Kiyoshi Ashida
Yuji Mizokami
Masahiro Asaka
Shigeyuki Matsui
Tatsuya Kanto
Satoshi Soen
Tsutomu Takeuchi
Hideyuki Hiraishi
Naoki Hiramatsu
机构
[1] Jichi Medical University,Division of Gastroenterology, Department of Medicine
[2] Komatsu Municipal Hospital,Department of Gastroenterology
[3] Fukui General Hospital,Department of Gastroenterology
[4] Izumino Hospital,Department of Cancer Preventive Medicine, Graduate School of Medicine
[5] Foundation for Detection of Early Gastric Cancer,Department of Data Science
[6] Osaka Saiseikai Nakatsu Hospital,Department of Gastroenterology and Hepatology
[7] Tsukuba University Hospital,Division of Rheumatology, Department of Internal Medicine
[8] Hokkaido University,Department of Gastroenterology
[9] The Institute of Statistical Mathematics,undefined
[10] Osaka University Graduate School of Medicine,undefined
[11] Nara Hospital Kinki University Faculty of Medicine,undefined
[12] Keio University School of Medicine,undefined
[13] Dokkyo Medical University,undefined
来源
Journal of Gastroenterology | 2012年 / 47卷
关键词
Non-steroidal anti-inflammatory drugs; Rheumatoid arthritis; Osteoarthritis; Gastric or duodenal ulcers; Prevention; Lansoprazole; Active-controlled trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:540 / 552
页数:12
相关论文
共 140 条
  • [31] Haber MM(undefined) isolates in Japan undefined undefined undefined-undefined
  • [32] Collis C(undefined)Changes in the prevalence of undefined undefined undefined-undefined
  • [33] Lukasik NL(undefined) infection and gastrointestinal diseases in the past 17 years undefined undefined undefined-undefined
  • [34] Raskin JB(undefined)Safety of proton pump inhibitor exposure undefined undefined undefined-undefined
  • [35] White RH(undefined)Long-term proton pump inhibitor therapy and risk of hip fracture undefined undefined undefined-undefined
  • [36] Jaszewski R(undefined)Safety of the long-term use of proton pump inhibitors undefined undefined undefined-undefined
  • [37] Korsten MA(undefined)undefined undefined undefined undefined-undefined
  • [38] Schubert TT(undefined)undefined undefined undefined undefined-undefined
  • [39] Fort JG(undefined)undefined undefined undefined undefined-undefined
  • [40] Lai KC(undefined)undefined undefined undefined undefined-undefined